Nisa Investment Advisors
MAZE

Nisa Investment Advisors’s Maze Therapeutics MAZE Stock Holding History

Nisa Investment Advisors’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.32K Sell
279
-1,125
-80% -$29.5K ﹤0.01% 2512
2026
Q1 		$41.9K Buy
1,404
+1,200
+588% +$53K ﹤0.01% 1742
2025
Q4 		$8.45K Buy
204
+178
+685% +$6.12K ﹤0.01% 2298
2025
Q3 		$674 Hold
26
– – ﹤0.01% 2805
2025
Q2 		$319 Buy
26
+8
+44% +$83 ﹤0.01% 2929
2025
Q1 		$198 Buy
+18
New +$217 ﹤0.01% 2929

Other funds holding MAZE

TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $498M AUM 267.53% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
MGB
Mass General Brigham Somerville, Massachusetts $361M AUM
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Nisa Investment Advisors's MAZE Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Maze Therapeutics (MAZE) stake by 80% in Q2 2026, selling an estimated $29.5K and leaving 279 shares worth $8.32K. The position accounts for ﹤0.01% of the portfolio, ranked #2512.

Nisa Investment Advisors first reported a position in MAZE in Q1 2025 and has held it in 6 quarters since. The position peaked at $41.9K in Q1 2026. 46 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

  • Nisa Investment Advisors held 279 shares of Maze Therapeutics worth $8.32K as of Q2 2026.
  • Nisa Investment Advisors sold 1,125 Maze Therapeutics shares in Q2 2026, an estimated $29.5K.
  • Maze Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2512 holding.
  • Nisa Investment Advisors first reported a position in Maze Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Nisa Investment Advisors's Maze Therapeutics position peaked at $41.9K in Q1 2026.
  • 46 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.